These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1617931)

  • 1. Roxithromycin versus amoxicillin-clavulanic acid in the treatment of respiratory tract infections.
    Lousbergh D; Jochems G; Everaert L; Puttemans M
    Diagn Microbiol Infect Dis; 1992; 15(4 Suppl):91S-95S. PubMed ID: 1617931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two oral antibiotics, roxithromycin and amoxicillin plus clavulanic acid, in lower respiratory tract infections.
    Dautzenberg B; Scheimberg A; Brambilla C; Camus P; Godard P; Guerin JC; Lemarie E; Rezvani Y; Rosembaum M; Tuchais E
    Diagn Microbiol Infect Dis; 1992; 15(4 Suppl):85S-89S. PubMed ID: 1617930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roxithromycin vs amoxycillin/clavulanic acid in lower respiratory tract infections.
    Brett W
    N Z Med J; 1994 Aug; 107(983):319-20. PubMed ID: 8052477
    [No Abstract]   [Full Text] [Related]  

  • 4. Roxithromycin 150 mg b.i.d. versus amoxycillin 500 mg/clavulanic acid 125 mg t.i.d. for the treatment of lower respiratory tract infections in general practice.
    Karalus NC; Garrett JE; Lang SD; Leng RA; Kostalas GN; Cursons RT; Cooper BC; Ryan CJ
    Infection; 1995; 23 Suppl 1():S15-20. PubMed ID: 7782110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoeconomic evaluation of roxithromycin versus amoxycillin/clavulanic acid in a community-acquired lower respiratory tract infection study.
    Scott WG; Cooper BC; Scott HM
    Infection; 1995; 23 Suppl 1():S21-4. PubMed ID: 7782111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roxithromycin and lower respiratory tract infections.
    Scott WG; Cooper BC; Scott HM; Karalus NC; Garrett J; Lang SD
    N Z Med J; 1994 May; 107(978):208. PubMed ID: 7980759
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of oral erythromycin ethylsuccinate and clavulanate-potentiated amoxicillin in the treatment of acute respiratory tract infections.
    Shanks N; Macklin J; Coles S
    Clin Ther; 1989; 11(6):812-9. PubMed ID: 2692823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Augmentin--current and prospective therapeutic indications].
    Mihălţan F
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988; 37(3):203-10. PubMed ID: 2855664
    [No Abstract]   [Full Text] [Related]  

  • 9. Is roxithromycin better than amoxicillin in the treatment of acute lower respiratory tract infections in primary care? A double-blind randomized controlled trial.
    Hopstaken RM; Nelemans P; Stobberingh EE; Muris JW; Rinkens PE; Dinant GJ
    J Fam Pract; 2002 Apr; 51(4):329-36. PubMed ID: 11978255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amoxycillin clavulanate: an assessment after 15 years of clinical application.
    Ball P; Geddes A; Rolinson G
    J Chemother; 1997 Jun; 9(3):167-98. PubMed ID: 9210001
    [No Abstract]   [Full Text] [Related]  

  • 11. Short-term use of amoxicillin-clavulanate during upper respiratory tract infection for prevention of acute otitis media.
    Heikkinen T; Ruuskanen O; Ziegler T; Waris M; Puhakka H
    J Pediatr; 1995 Feb; 126(2):313-6. PubMed ID: 7844685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study.
    Gris P
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():93-101. PubMed ID: 8818850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of respiratory tract infections in children: a study of a combination of amoxycillin and clavulanic acid.
    Fiocchi A; Zuccotti G; Bellù R; Marangione P; Riva E; Giovannini M
    J Int Med Res; 1990; 18(4):326-33. PubMed ID: 2227080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Augmentin].
    Foster M
    Antibiot Khimioter; 1992 Sep; 37(9):3-9. PubMed ID: 1444667
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of respiratory tract infections with a combination of amoxycillin and clavulanic acid.
    Karachalios GN
    Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):647-9. PubMed ID: 4093205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosing of amoxicillin/clavulanate given every 12 hours is as effective as dosing every 8 hours for treatment of lower respiratory tract infection. Lower Respiratory Tract Infection Collaborative Study Group.
    Calver AD; Walsh NS; Quinn PF; Baran C; Lonergan V; Singh KP; Orzolek WS
    Clin Infect Dis; 1997 Apr; 24(4):570-4. PubMed ID: 9145729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of lower respiratory tract infections.
    Brambilla C; Kastanakis S; Knight S; Cunningham K
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):118-24. PubMed ID: 1396725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amoxycillin with clavulanic acid.
    Toh C
    Aust Nurses J; 1989; 18(6):23. PubMed ID: 2912437
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized, comparative study to evaluate the efficacy and tolerability of a 3-day course of azithromycin versus a 10-day course of co-amoxiclav as treatment of adult patients with lower respiratory tract infections.
    Zachariah J
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():103-13. PubMed ID: 8818851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness and tolerance of amoxicillin/clavulanic acid ("Augmentin") in intravenous injections in adults].
    el Filali KM; el M'Daghri N; el Kabli H; Hajji M; Benbachir M; Himmich H
    Pharmatherapeutica; 1989; 5(5):329-37. PubMed ID: 2748691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.